HPPO-Derived Meroterpenoids from the Marine-Derived Fungus Penicillium sp. SCSIO 41691
Yu-Qian Tang,Xiao Liang,Qing-Hui Zou,Hui Cui,Lian-Xiang Luo,Shu-Hua Qi
DOI: https://doi.org/10.1021/acs.jnatprod.3c01121
IF: 5.1
2024-02-23
Journal of Natural Products
Abstract:Seven new 4-hydroxy-6-phenyl-2<i>H</i>-pyran-2-one (HPPO) derived meroterpenoids, 1-methyl-12a,12b-epoxyarisugacin M (<b>1</b>), 1-methyl-4a,12b-epoxyarisugacin M (<b>2</b>), 2,3-dihydroxy-3,4a-epoxy-12a-dehydroxyisoterreulactone A (<b>3</b>), 2-hydroxy-12a-dehydroxyisoterreulactone A (<b>4</b>), 3'-demethoxyterritrems B' (<b>5</b>), 4a-hydroxyarisugacin P (<b>6</b>), and 1-epi-arisugacin H (<b>7</b>), together with two known analogues (<b>8</b> and <b>9</b>), were isolated from the marine-derived fungal strain <i>Penicillium</i> sp. SCSIO 41691. Their structures were elucidated by spectroscopic methods, and the absolute configurations of compounds <b>1</b> and <b>3</b> were determined by single-crystal X-ray diffraction. Among them, <b>1</b> and <b>2</b> had a unique methyl migration in the basic meroterpenoid skeleton with a 12a,12b-epoxy or 4a,12b-epoxy group, and <b>3</b> was a highly oxygenated HPPO-derived meroterpenoid featuring a rare 6/5/6/6/6/6 hexacyclic system with a 3,4a-epoxy group. Biologically, <b>5</b> exhibited inhibitory activity against lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells with an IC<sub>50</sub> value of 21 μM, more potent than the positive control indomethacin.
plant sciences,chemistry, medicinal,pharmacology & pharmacy